| Adam et al., 2012 (2) | Retrospective registry-based observational study | 93,634 liver transplantations from 145 European centers | Liver transplantation outcomes and evolution | N/A | Improved survival over time due to advances in patient selection, surgery, and postoperative management. |
| Xi et al., 2025 (25) | Randomized Controlled Trial (RCT) | 80 liver transplant recipients (40 intervention, 40 control) | Nurse-led comprehensive postoperative care including psychological support, pain management, lifestyle guidance, and rehabilitation | Post-transplant | A comprehensive nursing intervention significantly reduced anxiety, depression, and insomnia scores compared with routine nursing care (P < 0.05). Improvements were sustained throughout the 12-month follow-up, supporting the effectiveness of multidisciplinary nursing in enhancing psychological recovery and quality of life after liver transplantation. |
| Ko et al., 2023 (42) | Mixed Methods Study (Cross-sectional survey + qualitative interviews/focus groups) | 252 adult solid organ transplant recipients (liver, kidney, and simultaneous liver–kidney transplant); 15 participants completed interviews/focus groups | Telehealth experience, satisfaction, perceived benefits and barriers | Post-transplant follow-up | Approximately 70% of recipients had used telehealth for transplant care. Overall satisfaction was high, particularly regarding convenience and effectiveness, while satisfaction with the reliability of telehealth systems was lower. Qualitative findings showed that telehealth was less suitable for recipients who were clinically or socially vulnerable, required urgent care, or had privacy concerns. The authors concluded that telehealth should be personalized according to individual patient needs and preferences in transplant follow-up. |
| Dolanbay & Ozkan, 2025 (40) | RCT | 90 adult liver transplant recipients (2 months–2 years posttransplant) | Web-based education, symptom management, immunosuppressive medication adherence | Post-transplant follow-up | Patients in the intervention group received 1 month of web-based education. Compared with the control group, they showed a significant reduction in the occurrence and distress of immunosuppressant-related symptoms and a significant improvement in adherence to immunosuppressive medications (P < 0.05). The study concluded that web-based educational interventions effectively improve medication adherence and reduce treatment-related symptom burden in liver transplant recipients. |
| Tutino et al., 2025 (65) | Multisite randomized controlled trial (Intervention development paper) | Adolescents and young adults after liver transplantation identified as non-adherent across multiple transplant centers | Telehealth behavioral intervention (iMALT), medication adherence, biomarker-guided intervention | Long-term posttransplant follow-up | The iMALT program developed a fully remote telehealth intervention to improve immunosuppressive medication adherence. It uniquely used the Medication Level Variability Index, derived from electronic health records, as a biomarker to identify non-adherent patients and dynamically adjust intervention intensity over time. The intervention incorporated behavioral theory, personalized coaching, and remote delivery to enhance engagement, reduce attrition, and minimize patient burden. The study demonstrates the feasibility of personalized, biomarker-driven telehealth interventions for improving long-term adherence in adolescent and young adult liver transplant recipients. |
| Zwarenstein et al., 2009 (11) | Cochrane systematic review | Five interprofessional intervention studies | Interprofessional collaboration | All phases | Interprofessional collaboration (IPC) interventions may improve health care processes and professional practice. |
| Yoshiga et al., 2025 (39) | Prospective descriptive single-group implementation study | 17 adult liver transplant recipients | Pharmacist-led post-discharge pharmaceutical consultation, medication adherence assessment, telehealth/in-person follow-up, and identification of medication-related problems (MRPs) | Post-transplant (Transition of Care / Post-discharge Follow-up) | A pharmacist-led post-discharge consultation program was feasible and effectively identified medication-related problems early. Most patients preferred telehealth (70.6%) and demonstrated high medication adherence (92.5%). The most common MRP was medication access (37.0%), and patients with unresolved MRPs received continued pharmacotherapeutic follow-up. The findings highlight the essential role of clinical pharmacists in ensuring safe transitions of care, improving medication management, and strengthening continuity of multidisciplinary posttransplant care. |
| Martin et al., 2014 (16) | Clinical Practice Guideline | Adult liver transplant candidates | Evaluation for liver transplantation | Pre-transplant | Recommends multidisciplinary evaluation before listing. |
| Jandovitz et al., 2018 (38) | Retrospective implementation study | 46 solid organ transplant patients (32 transplant recipients and 14 living donors) at a metropolitan academic medical center | Implementation of telemedicine pharmacy services, including medication reconciliation, medication education, pharmacotherapy review, adherence assessment, vaccination review, and referral to other providers | Post-transplant (Transition of Care / Early Follow-up) | A telemedicine pharmacy service was successfully implemented and improved access to transplant pharmacists during the transition from hospital to home. Medication reconciliation identified discrepancies requiring correction in 25% of patients, medication records were updated, adherence was assessed during all visits, and telemedicine facilitated multidisciplinary communication and continuity of care. The study demonstrated that pharmacist-led telemedicine is a feasible model for improving medication management and posttransplant follow-up. |
| Volk et al., 2011 (19) | Multicenter qualitative observational study | Four liver transplant centers | Selection committee decision-making | Pre-transplant | Multidisciplinary committees improve candidate evaluation but require clearer policies. |
| Vernooij et al., 2021 (66) | Retrospective observational study | 120 high-risk surgical patients | Multidisciplinary team (MDT) decision-making | Preoperative | MDT discussions changed perioperative management and reduced prolonged hospitalization. |
| Vernooij et al., 2023 (67) | Stepped-wedge cluster RCT protocol | 14 Dutch hospitals | MDT effectiveness | Preoperative | Evaluates effectiveness and cost-effectiveness of structured MDT meetings. |
| Plank et al., 2005 (23) | Pilot prospective study | 32 liver transplant patients | Immunonutrition | Pre- & Post-transplant | Nutritional intervention improved nutritional recovery and reduced infectious complications. |
| Boyer et al., 2011 (24) | Secondary analysis of RCT cohort | 99 hepatorenal syndrome (HRS) type-1 patients | Liver transplantation outcomes | Pre- & Post-transplant | Liver transplantation markedly improved survival regardless of pretransplant therapy. |
| Musgrave et al., 2013 (35) | Prospective observational study | Solid organ transplant recipients | Pharmacist medication reconciliation | Postoperative Follow-up | Pharmacist involvement significantly reduced medication errors after discharge. |
| Mulder et al., 2022 (33) | Observational cohort study | 291 liver transplant recipients | Clinical pharmacist consultation | Postoperative Follow-up | Pharmacist-led consultations reduced medication-related problems and unnecessary medications. |
| Ruiz et al., 2006 (54) | Retrospective case series | 98 combined liver-kidney transplant patients | Combined transplantation | Pre- & Post-transplant | Multidisciplinary management improved outcomes in complex dual-organ transplant patients. |
| Reeves et al., 2017 (62) | Cochrane systematic review | 9 RCTs (6540 participants) | Interprofessional collaboration | All phases | IPC interventions improve adherence to clinical practice and health care processes. |
| Saragih et al., 2024 (63) | Systematic review & meta-analysis | 10 RCTs (766 health care professionals) | Simulation-based interprofessional education | All phases | Simulation-based education improved interprofessional knowledge and teamwork. |
| Espindola et al., 2020 (29) | Methodological study (checklist development and Delphi content validation) | Expert panel (5 liver transplantation specialists); no patient participants | Development and content validation of a liver transplantation–specific surgical safety checklist based on the WHO Safe Surgery Checklist | Perioperative (Intraoperative / Surgical Safety) | A liver transplantation–specific surgical safety checklist was developed and validated using a two-round Delphi process. The final checklist contained 76 items across four surgical phases and achieved a Content Validity Index (CVI) of 0.87. The checklist was considered appropriate for improving patient safety, standardizing multidisciplinary communication, and reducing perioperative errors during liver transplantation |
| Mulder et al., 2021 (34) | Retrospective observational cohort study | 64 liver transplant recipients attending an outpatient clinic | Medication-related problems and clinical pharmacist interventions | Postoperative Follow-up | A clinical pharmacist identified 98 MRPs and 96 medication discrepancies among liver transplant recipients. The most common issues were adverse drug reactions, nonadherence, unnecessary medications, and undertreatment. Pharmacist-led interventions—including medication optimization, adherence counseling, and discontinuation of unnecessary drugs—were widely accepted by physicians and patients, resulting in sustained improvements in medication safety and adherence after one year. |
| Lichvar et al., 2023 (68) | Narrative review / Expert consensus | Solid organ transplant programs and transplant pharmacists | Expanded role of the transplant pharmacist in multidisciplinary transplant care | All phases (Pre-, Peri-, and Post-transplant) | This review highlights the evolving role of transplant pharmacists as integral members of the multidisciplinary transplant team. Pharmacists contribute to candidate evaluation, immunosuppressive therapy optimization, medication reconciliation, patient education, adverse drug reaction monitoring, adherence promotion, and long-term follow-up. The review emphasizes that expanding pharmacy services improves medication safety, clinical outcomes, and continuity of care throughout the transplant process. |
| Taber et al., 2015 (69) | National cross-sectional survey | 176 transplant pharmacists from 113 accredited U.S. solid organ transplant centers | Workforce and role of transplant pharmacists in multidisciplinary care | All phases (Pre-, Peri-, and Post-transplant) | The survey demonstrated that transplant pharmacists are integral members of multidisciplinary transplant teams. Their primary responsibilities include medication review, laboratory monitoring, medication therapy management, bedside rounds, patient education, documentation, and discharge medication coordination. Pharmacist involvement spans all phases of transplantation, although the level of participation varies among transplant centers. |
| Annunziato et al., 2013 (22) | Pilot comparative cohort study | 20 pediatric liver transplant recipients transitioning from pediatric to adult care | Role of a transition coordinator in continuity of care | Postoperative Follow-up (Transition to Adult Care) | The use of a dedicated transition coordinator improved medication adherence during the transfer from pediatric to adult transplant services, maintained psychosocial stability, and achieved high patient acceptance. The findings highlight the importance of coordinated multidisciplinary transition programs in ensuring continuity of posttransplant care. |
| Charriere et al., 2017 (18) | Retrospective cohort study | 387 patients with newly diagnosed hepatocellular carcinoma discussed in a dedicated multidisciplinary team meeting | Impact of MDT decision-making on treatment outcomes | Pre-transplant Planning | Patients whose treatment followed multidisciplinary team recommendations had significantly better overall survival than those who did not follow MDT decisions. The study demonstrates that structured MDT meetings optimize treatment selection, including liver transplantation, and improve clinical outcomes in patients with HCC. |
| Zhang et al., 2025 (20) | Retrospective cohort study | 393 patients with HCC undergoing liver transplantation | Impact of Multidisciplinary Tumor Board on survival after liver transplantation | Pre-transplant Planning & Peri-transplant Decision-making | Patients managed through a multidisciplinary tumor board demonstrated significantly improved overall survival and disease-free survival, particularly those exceeding the UCSF criteria. MDTB involvement optimized candidate selection, bridging therapies, perioperative management, and individualized treatment strategies, supporting the integration of multidisciplinary decision-making into liver transplantation programs. |
| Mulder et al., 2021 (34) | Retrospective observational cohort study | 64 adult liver transplant recipients attending an outpatient clinic | Medication-related problems and clinical pharmacist interventions | Postoperative Follow-up | A clinical pharmacist identified 98 MRPs and 96 medication discrepancies among liver transplant recipients. The most frequent MRPs were adverse drug reactions, medication nonadherence, unnecessary medications, and undertreatment. Pharmacist-led interventions—including medication optimization, adherence counseling, and discontinuation of unnecessary drugs—were widely accepted by physicians and patients, resulting in improved medication adherence and safer medication use after one year. |
| Stelzl et al., 2025 (28) | Prospective observational cohort study | | 8,546 operations performed by 1,109 surgeon–assistant dyads across 14 surgical departments in 4 university hospitals | Perioperative (Operating room teamwork) | Greater familiarity between the attending surgeon and assistant surgeon was significantly associated with fewer major adverse events, including major surgical complications and unplanned reoperations. Stable surgical teams improved coordination and patient safety, supporting continuity of multidisciplinary operating room teams. |
| Cardillo et al., 2006 (27) | Comparative retrospective cohort study (North Italian Transplant Program) | - | 1,449 liver transplant recipients across 7 transplant centers (1,126 whole liver transplant; 323 split liver transplant) | Perioperative / Transplant program | Split liver transplantation achieved overall patient and graft survival comparable to whole liver transplantation. The organized multicenter transplant program increased pediatric transplantation, reduced waiting-list mortality in children, and decreased adult waiting-list dropout, highlighting the importance of coordinated multidisciplinary transplant teams and structured transplant programs. |
| Deng et al., 2026 (55) | Narrative review with single-center implementation experience | - | Literature review on liver transplantation and implementation of an Integrated Care Management model at a liver transplant center | Post-transplant (Long-term follow-up) | The authors propose an ICM model to address gaps in long-term liver transplant care. The model emphasizes coordinated multidisciplinary follow-up involving transplant surgeons, hepatologists, pharmacists, nurses, nutritionists, rehabilitation specialists, and psychosocial support teams. Comprehensive management of immunosuppression, graft monitoring, infection prevention, metabolic complications, and patient education is recommended to improve long-term graft survival, quality of life, and overall clinical outcomes. |
| Tian et al., 2021 (43) | Prospective cohort study | | 110 adult liver transplant recipients randomized to telemedicine-assisted follow-up (n = 52) or usual follow-up (n = 50) after discharge. Of the 110 participants, 60 were eligible for telemedicine and 50 for usual care. In the telemedicine group, 6 were excluded because they lacked a home wireless network and 2 did not start the program because they could not use the system; the full analysis set therefore comprised 52 telemedicine and 50 usual-care participants (102 total). | Post-transplant (Follow-up) | Telemedicine-based multidisciplinary follow-up significantly reduced initial hospitalization duration, health care costs, and 30-day readmission rates compared with usual care. Daily remote monitoring by transplant specialists improved early detection of complications, medication adherence, self-management, rehabilitation, and health-related quality of life, while maintaining similar 12-month survival. |
| Xu-Stettner et al., 2023 (44) | Single-center comparative observational study | | 28 adult liver transplant recipients with 182 transplant pharmacist encounters (85 in-clinic, 42 telehealth, 55 asynchronous visits) | Post-transplant (Follow-up/Telehealth) | Telehealth consultations by transplant pharmacists resulted in treatment decisions comparable in number and clinical importance to in-person clinic visits. The findings support telehealth as an effective approach for pharmacist-led posttransplant medication management, enabling continuous multidisciplinary follow-up without compromising quality of care. |
| Mulder et al., 2022 (33) | Observational cohort study | 291 liver transplant recipients | Outpatient medication consultation by a clinical pharmacist | Patients receiving pharmacist consultation had significantly fewer MRPs, fewer unnecessary medications, fewer untreated indications, and fewer dosing errors. Medication adherence remained high. | Integration of a clinical pharmacist into posttransplant multidisciplinary care improves medication safety and reduces MRPs. |
| Xu-Stettner et al., 2023 (44) | Single-center comparative study | 28 liver transplant recipients | Telehealth vs. in-clinic transplant pharmacist visits | No significant difference in the number or importance of pharmacist treatment decisions between telehealth and face-to-face visits. | Telehealth enables transplant pharmacists to provide clinical care comparable to traditional clinic visits. |
| Koc et al., 2022 (45) | Prospective cohort study | 115 liver transplant recipients | Telemedicine-based Remote Monitoring Program | Remote monitoring increased tacrolimus monitoring, maintained lower tacrolimus levels safely, and did not increase rejection or hospitalization. | Telemedicine is feasible and safe for long-term follow-up of stable liver transplant recipients. |
| Tian et al., 2021 (43) | Cohort study | 110 liver transplant recipients. The full analysis set included 102 participants (52 telemedicine and 50 usual care) after 8 telemedicine participants were excluded or did not start the program. | Telemedicine follow-up using daily remote monitoring by transplant specialists | Reduced initial hospital stay, lower hospitalization costs, significantly fewer 30-day readmissions, and improved medication adherence and self-management. | Telemedicine enhances postoperative recovery and follow-up outcomes after liver transplantation. |
| Park et al., 2021 (46) | Retrospective observational study | 157 transplant recipients (385 virtual pharmacist visits) | Virtual ambulatory transplant pharmacist service during COVID-19 | Pharmacists identified 778 medication discrepancies and performed 891 interventions. Over 60% of visits detected medication-related errors. | Virtual transplant pharmacist services improve medication management and continuity of multidisciplinary transplant care. |
| Khalil et al., 2024 (70) | Cross-sectional survey | 45 transplant pharmacists | Telehealth experience among transplant pharmacists during COVID-19 | Telehealth utilization increased dramatically during the pandemic; 91% wished to continue telehealth after COVID-19. | Telehealth is a valuable component of multidisciplinary transplant pharmacy practice and should continue beyond the pandemic. |
| Deng et al., 2026 (55) | Narrative review and single-center implementation experience | Literature review + institutional experience | ICM model for liver transplantation | Comprehensive multidisciplinary management addressing perioperative care, immunosuppression, complications, long-term follow-up, and patient education may improve long-term outcomes after transplantation. | An integrated multidisciplinary care model is recommended to optimize long-term outcomes in liver transplant recipients. |
| Salerno et al. (30) | Before–after cohort study | 125 liver transplant recipients | Multidisciplinary Fast-Track (Enhanced Recovery) protocol involving transplant surgeons, anesthesiologists, hepatologists, nurses, pharmacists, dietitians, physical therapists, and patient education. The protocol included reduced corticosteroid exposure, early extubation, multimodal analgesia, early drain removal, early nutrition, early mobilization, and standardized discharge planning. | Hospital length of stay, delirium, ICU length of stay, acute rejection, 30-day readmission | Following implementation of the Fast-Track protocol, the median hospital length of stay decreased from 12 to 10 days (P = 0.025), while the incidence of posttransplant delirium decreased from 25.8% to 8.6% (P = 0.013). No significant increase was observed in acute rejection, ICU stay, or 30-day readmission, indicating that a standardized multidisciplinary enhanced recovery pathway is both safe and effective for improving postoperative outcomes after liver transplantation. |
| Mahmud et al., 2019 (37) | Retrospective cohort study | 362 liver transplant recipients at a tertiary referral transplant center | Nurse practitioner (NP)-based multidisciplinary posttransplant care program, including dedicated weekend inpatient NP coordinators, expanded outpatient NP clinic availability, post-discharge care coordination, patient education, and close follow-up in collaboration with the transplant team. | 30-day and 90-day hospital readmission rates, risk factors for readmission | Implementation of the NP-based care program was associated with a significant reduction in 30-day readmissions (HR = 0.60, 95% CI 0.39 - 0.90; P = 0.02) and 90-day readmissions (HR = 0.49, 95% CI 0.34 - 0.71; P < 0.001). Peri-transplant dialysis and retransplantation increased the risk of readmission. The findings demonstrate that expanding the role of advanced practice nurses within the multidisciplinary transplant team improves continuity of care, reduces hospital readmissions, and enhances the efficiency of post-liver transplantation management. |
| Serper et al., 2015 (21) | Multicenter observational study | 105 liver transplant recipients from two US transplant centers | Multidisciplinary posttransplant medication management, including assessment of medication knowledge, regimen use, and adherence by the transplant care team through structured interviews and medical record review. The intervention emphasized patient education, medication counseling, and monitoring of immunosuppressive therapy. | Medication adherence, treatment knowledge, demonstrated regimen use, rehospitalization, clinical outcomes | Thirty-two percent of recipients were classified as nonadherent based on tacrolimus blood levels. Higher treatment knowledge and correct medication regimen use were independently associated with a 15% reduction (IRR = 0.85) and 13% reduction (IRR = 0.87) in posttransplant rehospitalizations, respectively. Lower health literacy, lower income, polypharmacy, and shorter time since transplantation were associated with poorer medication knowledge and greater nonadherence. These findings highlight that patient education, continuous medication management, and multidisciplinary follow-up are essential for improving adherence and reducing adverse clinical outcomes after liver transplantation. |
| Chaney et al., 2016 (31) | Retrospective observational study | Adult recipients undergoing deceased-donor liver transplantation at a single transplant center | NPs and physician assistants (PAs) were integrated into the multidisciplinary liver transplant program, participating in perioperative management, inpatient and outpatient care, care coordination, patient education, and resident/fellow training. | Length of hospital stay, warm ischemia time, patient survival, graft survival, transplant program efficiency | Despite treating patients with higher MELD scores and longer waiting times, incorporation of NPs and PAs into the multidisciplinary transplant team did not increase hospital length of stay or warm ischemia time. Patient and graft survival improved and remained at or above expected benchmarks. In addition, NPs and PAs enhanced continuity of care and contributed substantially to the education of surgical residents and transplant fellows. These findings support the essential role of advanced practice providers in improving the quality, efficiency, and outcomes of liver transplantation programs. |
| Lichvar et al., 2023 (68) | Expert review / Position paper | | Evidence synthesized from published studies on solid organ transplantation (no direct patient cohort) | Transplant pharmacist as an integral member of the multidisciplinary transplant team across all phases of transplantation, including pretransplant evaluation, perioperative care, posttransplant management, long-term follow-up, immunosuppressive therapy optimization, medication safety, patient education, and therapeutic drug monitoring. | Evolution of the transplant pharmacist's role, medication safety, multidisciplinary collaboration, clinical outcomes, professional development |
| Güzel Karahan et al., 2025 (36) | Prospective observational study | | 373 hospitalized liver transplant recipients (ward and ICU) | Clinical pharmacist-led medication review using the PCNE v9.1 classification to identify MRPs, evaluate causes, and provide pharmacist interventions in collaboration with the transplant team. | MRPs, acceptance of pharmacist interventions, causes of MRPs, risk factors for MRPs |